Catabasis Pharmaceuticals Inc (CATB)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -69.059 | -94.186 | -90.667 | -64.962 | -83.599 | -222.795 | -28.946 | -30.04 |
Return on Equity (%) | -90.627 | -133.881 | -110.712 | -74.419 | -97.658 | -239.185 | -30.178 | -31.396 |
Return on Invested Capital (%) | -81.227 | -125.636 | -113.612 | -77.404 | -98.837 | -239.572 | -31.335 | -36.181 |
Operating Margin (%) | N/A | -5380.4 | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | -5472.8 | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 1.546 | 0.499 | 3.039 | 2.873 | 2.025 | 9.396 | 8.044 | 6.698 |
Earnings Per Share | -1.916 | -1.157 | -2.25 | -2.115 | -1.857 | -14.974 | -1.885 | -2.008 |
Cash Per Share | 1.254 | 0.692 | 1.33 | 0.796 | 1.241 | 6.646 | 0.746 | 4.836 |
Working Capital Per Share | 1.658 | 0.484 | 3.022 | 2.728 | 1.988 | 9.363 | 7.95 | 6.596 |
Operating Profit Per Share | N/A | 0.021 | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -1.916 | -1.157 | -2.25 | -2.115 | -1.857 | -14.974 | -1.885 | -2.008 |
EBITDA Per Share | -1.916 | -1.157 | -2.25 | -2.115 | -1.857 | -14.974 | -1.885 | -2.008 |
Free Cash Flow Per Share | -1.913 | -1.168 | -2.261 | -2.116 | -1.856 | -13.095 | -1.881 | -2.008 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 18,82M | 23,65M | 11,5M | 12,43M | 20,08M | 13,02M | 27,5M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 15,75M | 27,5M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 309,97M |
Ratio cours/bénéfice | -4,25 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 1,77 |
Ratio prix/valeur comptable | 1,27 |
Rendement de dividende | - |
Actions en circulation | 36,3M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales